Li Xiong
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 10
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 8
-
- Photodynamic Therapy Research Studies 18
- Ferroptosis and cancer prognosis 12
- Immunology top 5%
-
- Nanoplatforms for cancer theranostics 21
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 17
-
- Liver Disease Diagnosis and Treatment 11
- Co-authors
- Yu WenXiongying MiaoZijian ZhangThomas L. DawsonHong YuH. Shelton EarpHeng ZouZhulin Yang
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Li Xiong
116 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Hepatology 348
- Cancer Research 578
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 736
- Immunology 461
Countries citing papers authored by Li Xiong
This map shows the geographic impact of Li Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Xiong more than expected).
Fields of papers citing papers by Li Xiong
This network shows the impact of papers produced by Li Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Xiong. The network helps show where Li Xiong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Li Xiong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 25 | |
| 7 | 2023 | 5 | |
| 8 | 2022 | 11 | |
| 9 | 2022 | 4 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 12 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 15 | |
| 14 | 2020 | 17 | |
| 15 | 2018 | 46 | |
| 16 | Photodynamic Therapy for Unresectable Cholangiocarcinoma | 2012 | 1 |
| 17 | Advances in Photodynamic Therapy for Gastric Cancer | 2012 | 1 |
| 18 | 2012 | 50 | |
| 19 | 2010 | 8 | |
| 20 | 1995 | 312 |
About Li Xiong
Li Xiong is a scholar working on Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 123 papers that have together received 3.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (21 papers), Photodynamic Therapy Research Studies (18 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Ferroptosis and cancer prognosis (12 papers), Liver Disease Diagnosis and Treatment (11 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Pancreatic and Hepatic Oncology Research (8 papers). The work is most often cited by research in Hepatology (348 citations), Cancer Research (578 citations) and Oncology (1.0k citations). Li Xiong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yu Wen, Xiongying Miao, Zijian Zhang, Thomas L. Dawson, Hong Yu, H. Shelton Earp, Heng Zou, Zhulin Yang, Yu Wen and Yu Wen. Their work appears in journals such as Advanced Materials, Nature Immunology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.